Gene · 4485
Papers4,329
Newest first. Swiss-Prot's references are curated; PubTator's text mining finds papers that name the gene, not always ones about it.
181 to 200 of 4,329
Download this page as JSON| Title | Journal | Year | PMID | Found by | Source |
|---|---|---|---|---|---|
| YAP represses the TEAD-NF-κB complex and inhibits the growth of clear cell renal cell carcinoma. | Sci Signal | 2024 | 38954637 | PubTator, text mining | PubMed |
| Integrin-Linked Kinase in the Development of Gastric Tumors Induced by Helicobacter pylori: Regulation and Prevention Potential. | Helicobacter | 2024 | 38951739 | PubTator, text mining | PubMed |
| Harnessing the potential of hydrogels for advanced therapeutic applications: current achievements and future directions. | Signal Transduct Target Ther | 2024 | 38945949 | PubTator, text mining | PubMed |
| Novel Protein Biomarkers and Therapeutic Targets for Type 1 Diabetes and Its Complications: Insights from Summary-Data-Based Mendelian Randomization and Colocalization Analysis. | Pharmaceuticals (Basel) | 2024 | 38931433 | PubTator, text mining | PubMed |
| Targeting of CYP2E1 by miRNAs in alcohol-induced intestine injury. | Mol Cells | 2024 | 38901530 | PubTator, text mining | PubMed |
| Genetic association analysis in sugarcane (Saccharum spp.) for sucrose accumulation in humid environments in Colombia. | BMC Plant Biol | 2024 | 38886648 | PubTator, text mining | PubMed |
| [Retracted] Mst1 regulates non‑small cell lung cancer A549 cell apoptosis by inducing mitochondrial damage via ROCK1/F‑actin pathways. | Int J Oncol | 2024 | 38874004 | PubTator, text mining | PubMed |
| EGFR and Hippo signaling pathways are involved in organophosphate esters-induced proliferation and migration of triple-negative breast cancer cells. | Environ Sci Pollut Res Int | 2024 | 38856849 | PubTator, text mining | PubMed |
| Scaffolding Supports the Hippo. | Cell Mol Gastroenterol Hepatol | 2024 | 38848765 | PubTator, text mining | PubMed |
| MST1 knockdown inhibits osteoarthritis progression through Parkin-mediated mitophagy and Nrf2/NF-κB signalling pathway. | J Cell Mol Med | 2024 | 38842136 | PubTator, text mining | PubMed |
| Corrigendum to "Inhibition of MST1 ameliorates neuronal apoptosis via GSK3β/β-TrCP/NRF2 pathway in spinal cord injury accompanied by diabetes" [Redox Biol. 71C (2024) 103104]. | Redox Biol | 2024 | 38806302 | PubTator, text mining | PubMed |
| Amplification of Hippo Signaling Pathway Genes Is Governed and Implicated in the Serous Subtype-Specific Ovarian Carcino-Genesis. | Cancers (Basel) | 2024 | 38730733 | PubTator, text mining | PubMed |
| Comparative proteomics analysis of samples from hepatic cystic echinococcosis patients using data-independent acquisition approach. | J Proteomics | 2024 | 38697285 | PubTator, text mining | PubMed |
| Hippo pathway activated by circulating reactive oxygen species mediates cardiac diastolic dysfunction after acute kidney injury. | Biochim Biophys Acta Mol Basis Dis | 2024 | 38648903 | PubTator, text mining | PubMed |
| The Hippo kinases control inflammatory Hippo signaling and restrict bacterial infection in phagocytes. | mBio | 2024 | 38624208 | PubTator, text mining | PubMed |
| UNVEILING THE PROTECTIVE MECHANISMS OF PUERARIN AGAINST ACUTE LUNG INJURY: A COMPREHENSIVE EXPLORATION OF THE ROLES AND MECHANISMS OF MST1/ERS SIGNALING. | Shock | 2024 | 38598838 | PubTator, text mining | PubMed |
| The possible correlation between miR-762, Hippo signaling pathway, TWIST1, and SMAD3 in lung cancer and chronic inflammatory diseases. | Sci Rep | 2024 | 38589525 | PubTator, text mining | PubMed |
| Overexpression of Mst1 Reduces Gastric Cancer Cell Viability by Repressing the AMPK-Sirt3 Pathway and Activating Mitochondrial Fission [Retraction]. | Onco Targets Ther | 2024 | 38586816 | PubTator, text mining | PubMed |
| Identification of prospective aging drug targets via Mendelian randomization analysis. | Aging Cell | 2024 | 38572516 | PubTator, text mining | PubMed |
| Structure-guided discovery of protein and glycan components in native mastigonemes. | Cell | 2024 | 38552612 | PubTator, text mining | PubMed |
gene-search-2026-11-11-0.2.0
Sources 12
- ClinicalTrials.gov's posted results, through CTTI's AACTFreely available. Acknowledgement requested
- ChEMBL, through Open TargetsCC BY-SA 3.0
- ClinicalTrials.govNo license stated
- EMBL-EBI's patent proteinsNo added restrictions. Attribution expected
- GenBank's patent filesNo restrictions from NCBI. Submitters may hold rights
- HGNCCC0
- NCBI GenePublic domain (US government)
- NIH's project files and grant-paper linksPublic domain
- Open TargetsCC0 1.0
- PubMedNLM's terms
- PubTator 3Public domain
- UniProtCC BY 4.0
Each source's terms
- ClinicalTrials.gov's posted results, through CTTI's AACTClinicalTrials.gov data via Aggregate Analysis of ClinicalTrials.gov (AACT), CTTI. CTTI makes its materials freely available and requests acknowledgement. https://aact.ctti-clinicaltrials.org/documentation/299
- ChEMBL, through Open TargetsCC BY-SA 3.0, for the parts from ChEMBL. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- ClinicalTrials.govnone stated
- EMBL-EBI's patent proteinsEMBL-EBI's patent protein files from the EPO, JPO, KIPO and USPTO. EMBL-EBI: "EMBL-EBI itself places no additional restrictions on the use or redistribution of the data available via its Data Resources and Tools other than those provided by the original data owners" and "EMBL-EBI expects attribution (e.g. in publications, services or products) for the use of any of its Data Resources and Tools." Read on 11 Nov 2026 at https://www.ebi.ac.uk/about/terms-of-use
- GenBank's patent filesGenBank's patent files. NCBI: "NCBI places no restrictions on the use or distribution of the GenBank data. However, some submitters may claim patent, copyright, or other intellectual property rights in all or a portion of the data they have submitted." Read on 11 Nov 2026 at https://www.ncbi.nlm.nih.gov/genbank/about/
- HGNCCC0: https://www.genenames.org/about/license/
- NCBI GeneNone named for the file. NCBI says information created by or for the US government on its site is in the public domain, and asks that NLM be acknowledged: https://www.ncbi.nlm.nih.gov/home/about/policies/
- NIH's project files and grant-paper linksPublic domain (NIH RePORTER)
- Open TargetsCC0 1.0. Open Targets asks that users cite its latest paper: Buniello et al. 2025, Open Targets Platform: facilitating therapeutic hypotheses building in drug discovery, Nucleic Acids Research 53(D1):D1467, PMID 39657122. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- PubMedNLM's terms
- PubTator 3Public domain
- UniProtCC BY 4.0. UniProt's licence file: "All databases and documents in the UniProt FTP directory may be copied and redistributed freely, without advance permission, provided that this copyright statement is reproduced with each copy." UniProt asks that users cite its latest paper: The UniProt Consortium, UniProt: the Universal Protein Knowledgebase in 2025, Nucleic Acids Research 53:D609-D617, https://doi.org/10.1093/nar/gkae1010. Read on 9 Nov 2026 at https://www.uniprot.org/help/license
ClinicalTrials.gov's data carry an international copyright outside the United States: https://clinicaltrials.gov/about-site/terms-conditions.
For software
Read this list from software.
Twenty rows a page, as JSON. No key.
GET https://conductscience.org/api/genes/v1/4485/papers?page=10